Altamont Pharmaceutical Holdings LLC and its affiliates, and certain of our existing stockholders have indicated an interest in purchasing an aggregate of up to approximately $4.5 million of shares of common stock and warrants in this offering at the public offering price. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may sell more, less or no securities in this offering to these potential investors, or the potential investors may determine to purchase more, less or no securities in this offering. The underwriters will not receive any underwriting discount or commission on any securities purchased by these potential investors.
Good luck to all longs...
News 
Market Data 
Discover 
